Implementing Agile Solutions for Vaccine Clinical Trials

This case study outlines the execution of a Phase III clinical trial for a vaccine against a preventable disease in China. The study was conducted in hospital emergency departments and required meticulous planning, site support, and oversight to ensure participant safety and data quality. The sponsor, a Chinese biotech company, sought full-service support from a contract research organization (CRO) to meet aggressive timelines while managing costs. The case study details how Fortrea collaborated with the sponsor to address challenges such as complex site processes and recruitment delays. Strategies included rapid site activation, ensuring proper vaccine handling, and enhancing site support to boost enrollment. The study successfully enrolled 675 participants at 28 sites, achieving milestones 1.5 months ahead of schedule and generating cost savings for the sponsor. The case study emphasizes the importance of agile, site-centric solutions in delivering successful clinical trials.